Volatile inhalant-induced anxiety transtorno is characterised by anxiety symptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive autonomic arousal, avoidance behaviour) that develop during or soon after intoxicação com or abstinência from volatile inhalants. The intensity or duration of the symptoms is substantially in excess of anxiety symptoms that are characteristic of Volatile inhalant intoxicação or Volatile inhalant abstinência. The amount and duration of volatile inhalant uso must be capable of producing anxiety symptoms. The symptoms are not better explained by a primary mental transtorno (e.g., an Anxiety and Fear-Related transtorno, a Depressive transtorno com prominent anxiety symptoms), as might be the case if the anxiety symptoms preceded the onset of the volatile inhalant uso, if the symptoms persist for a substantial period of time after cessation of the volatile inhalant uso or abstinência, or if there is other evidence of a pre-existing primary mental transtorno com anxiety symptoms (e.g., a history of prior episodes not associated com volatile inhalant uso).